Application 215402
- Type
- ANDA
- Sponsor
- CARNEGIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETRAVIRINE | ETRAVIRINE | TABLET;ORAL | 100MG | No | No |
| 002 | ETRAVIRINE | ETRAVIRINE | TABLET;ORAL | 200MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69315-285 | ETRAVIRINE | ETRAVIRINE | Leading Pharma, LLC | ANDA | Current |
| 69315-286 | ETRAVIRINE | ETRAVIRINE | Leading Pharma, LLC | ANDA | Current |
| 80005-112 | ETRAVIRINE | ETRAVIRINE | Carnegie Pharmaceuticals LLC | ANDA | Current |
| 80005-113 | ETRAVIRINE | ETRAVIRINE | Carnegie Pharmaceuticals LLC | ANDA | Current |